What are the possible causes of hepatomegaly observed on computed tomography (CT) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Hepatomegaly on CT Scan

Hepatomegaly on CT scan has a broad differential diagnosis that includes vascular congestion, metabolic storage diseases, infiltrative processes, malignancy, and cirrhosis-related changes—each with characteristic imaging patterns that guide diagnosis.

Vascular and Congestive Causes

Budd-Chiari syndrome presents with striking hepatomegaly, ascites, and abdominal pain on CT, showing hepatic venous outflow obstruction with characteristic zonal enhancement and inhomogeneous parenchymal enhancement (reticular pattern) 1. Doppler ultrasound has >75% sensitivity for diagnosis, but CT with contrast definitively demonstrates the obstruction pattern 1.

Congestive hepatopathy from cardiac disease shows hepatomegaly with hepatic vein distention and characteristic enhancement patterns 2, 3. In Fontan patients specifically, CT demonstrates hepatomegaly, zonal enhancement, inhomogeneous parenchymal enhancement, and hypervascular nodules that correlate with hepatic vein pressure 4. The CT appearance may mimic neoplastic infiltration, making recognition critical to avoid unnecessary workup 3.

Metabolic Storage Diseases

Glycogen storage diseases cause hepatomegaly with markedly elevated hepatic CT attenuation (>80 HU) due to glycogen accumulation 5, 6. This can occur rapidly—within days—following massive insulin doses with glucose supplementation 6. The liver shows uniform glycogen distribution without the focal lesions seen in other storage diseases 5.

Other storage diseases including Gaucher disease, Niemann-Pick disease, and acid sphingomyelinase deficiency present with hepatosplenomegaly 5, 7. ASMD specifically shows hepatomegaly as the primary manifestation, with focal liver abnormalities common on CT and potential for progression to cirrhosis 7.

Infiltrative and Malignant Processes

Malignant infiltration causes massive hepatic enlargement on CT, particularly with breast cancer, small cell lung cancer, lymphoma, and melanoma 2. In patients with acute liver failure and massive hepatomegaly, imaging and biopsy are essential to confirm or exclude malignancy before considering transplantation 2.

Hepatic AL amyloidosis demonstrates specific CT/MRI features: diffuse hepatomegaly with decreased hepatic attenuation, delayed enhancement, poor visualization or stenosis of main hepatic veins, and periportal edema in all cases 8. Laboratory findings show markedly elevated alkaline phosphatase and GGT with normal or mildly elevated transaminases 8.

Cirrhosis and Fibrosis

Cirrhosis shows morphologic changes on CT including liver surface nodularity, right lobe atrophy, caudate lobe hypertrophy, and the right hepatic posterior "notch" 9. However, sensitivity of these features for excluding fibrosis is too low for definitive diagnosis 9. Contrast-enhanced CT demonstrates parenchymal heterogeneity and lattice-like macroscopic bands of fibrosis 9.

Hypertrophic changes occur in multiple conditions including cirrhosis (most common), Budd-Chiari syndrome, post-hepatectomy, cholangiocarcinoma, and portal vein embolization 10. CT readily detects these changes, and their discovery should prompt evaluation for neoplastic etiology or portal hypertension 10.

Cystic Fibrosis-Related Liver Disease

In CF patients, hepatomegaly is the most common physical finding (up to 30% prevalence) 11. CT/ultrasound screening every 2 years from age 3 is recommended, with annual physical examination for hepatosplenomegaly 11.

Drug-Induced Hepatomegaly

Corticosteroid therapy causes rapid hepatomegaly within days due to excessive glycogen accumulation in hepatocytes 12. This is benign and reversible, showing normal liver architecture on biopsy with hepatocytes distended by glycogen 12.

Acute Liver Injury

Ischemic hepatitis ("shock liver") from hypoperfusion shows hypoenhancement of liver parenchyma on contrast-enhanced CT 13. Acute hepatitis demonstrates arterial heterogeneity, periportal hypoattenuation, perihepatic lymphadenopathy (>7 mm), and ascites 13. Gallbladder wall thickening (mean 5.2 mm) predicts severe hepatitis 13.

Key Diagnostic Pitfalls

  • Congestive hepatomegaly may mimic neoplastic infiltration—look for cardiac dysfunction and characteristic enhancement patterns 3
  • Rapid-onset glycogen storage from insulin/glucose can be mistaken for acute liver disease—check CT attenuation values 6
  • Hepatic amyloidosis requires high suspicion when ALP/GGT are markedly elevated with preserved transaminases and characteristic vascular findings 8
  • In patients with prior cancer history and massive hepatomegaly, always obtain imaging and consider biopsy to exclude malignant infiltration 2

References

Guideline

acr appropriateness criteria® chronic liver disease.

Journal of the American College of Radiology, 2020

Research

Hepatomegaly following short-term high-dose steroid therapy.

Journal of pediatric gastroenterology and nutrition, 1986

Guideline

acr appropriateness criteria® abnormal liver function tests.

Journal of the American College of Radiology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.